To see whether a drop in ʟ-arginine concentration associated with tumor progression leads to impaired T-cell proliferation, we have adoptively transferred OT-I cells into control and Vκ*MYC-bearing mice and challenged mice with OVA. The gene discussed is MYC; the disease is neoplasm.